• Bruce K Rubin.
• Department of Pediatrics, Wake Forest University, School of Medicine Medical Center, Boulevard Winston-Salem, Winston-Salem, NC 27157-1081, USA. brubin@wfubmc.edu
• Paediatr Respir Rev. 2006 Jan 1; 7 Suppl 1: S76-9.

AbstractAlthough aerosol therapy is most commonly used to treat asthma and COPD, there are a large number of aerosol medications now used or in development for other diseases. Mucoactive agents have long been available by aerosol, but now we have truly effective drugs to improve effective airway clearance including dornase alfa, hyperosmolar saline, and aerosol surfactant. Inhaled antibiotics are available for the treatment of cystic fibrosis, bronchiectasis and other chronic airway infections. With the development of devices that can target aerosol to the deep lung, the opportunity to deliver medications systemically by the aerosol route has become a reality. Insulin, recently approved in the US as aerosol therapy, and other peptides are systemically absorbed from the distal airway and alveolus. Aerosol gene transfer therapy to correct abnormalities associated with cystic fibrosis, primary ciliary dyskinesia and other airway diseases also holds great potential.

22 keywords...

hide…